You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0372 Effect of Certolizumab Pegol on Workplace and Household Productivity in US Patients with Rheumatoid Arthritis with or without Prior Anti-Tumor Necrosis Factor Exposure: Results from the PREDICT Study

Citation Tools

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - anti-TNF therapy
AB0372 Effect of Certolizumab Pegol on Workplace and Household Productivity in US Patients with Rheumatoid Arthritis with or without Prior Anti-Tumor Necrosis Factor Exposure: Results from the PREDICT Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kavanaugh A, Mease P, Strand V, et al
AB0372 Effect of Certolizumab Pegol on Workplace and Household Productivity in US Patients with Rheumatoid Arthritis with or without Prior Anti-Tumor Necrosis Factor Exposure: Results from the PREDICT Study
Annals of the Rheumatic Diseases 2014;73:927-928.